Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting

Information
Discussion (0)
Usage statistics

Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting - Muntañola, Ana (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Arguiñano, José M (Hospital Universitario de Navarra) ; Dávila, Julio (Complejo Asistencial de Ávila) ; de Villambrosia, Sonia González (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Carpio Segura, Cecilia del Carmen (Universitat Autònoma de Barcelona. Departament de Medicina) ; Jiménez-Ubieto, Ana (Hospital Universitario 12 de Octubre (Madrid)) ; Salar, Antonio (Universitat Pompeu Fabra)

Comments (0) | Reviews (0)

Be the first to review this document.

Add review

Rate this article:

Give a title to your review:

Write your review:

Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.

Similar records